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PCoronary Artery Disease
ubclinical Coronary Artery
therosclerosis in Patients With Erectile Dysfunction
milio Chiurlia, PHD,* Roberto D’Amico, MD,† Carlo Ratti, MD,* Antonio R. Granata, MD,‡
enato Romagnoli, MD,§ Maria G. Modena, MD, FACC*
odena, Italy
OBJECTIVES The purpose of our study was to assess the prevalence and extent of coronary artery
atherosclerosis in asymptomatic patients with vascular erectile dysfunction (ED).
BACKGROUND An association between ED and ischemic heart disease has been suggested, but it is unknown
if it represents a marker of subclinical coronary atherosclerosis.
METHODS We studied 70 consecutive patients with vascular ED, evaluated by penile Doppler, and 73
control subjects with no history of coronary artery disease. We measured traditional coronary
risk factors, circulating levels of C-reactive protein (CRP), endothelial function by ultrasound
of brachial artery, and coronary artery calcification by multi-slice computed tomography.
RESULTS The patients and the control group were similar for age, race, and coronary risk score. Patients
with ED had significantly higher high-sensitivity C-reactive protein levels (2.62 vs. 1.03
mg/l, p 0.001). Flow-mediated dilation of the brachial artery was more impaired in patients
with ED than in controls (2.36 vs. 3.92, p  0.001). Coronary artery calcification was more
frequent in individuals with ED than in control subjects (p  0.01). Multiple logistic
regression analysis showed that patients with ED had an overall odds ratio of 3.68 for having
calcium score above the 75th percentile, compared to the controls.
CONCLUSIONS Coronary atherosclerosis is more severe in patients with vascular ED; ED predicts the
presence and extent of subclinical atherosclerosis independent of traditional risk factors for
cardiovascular disease. Thus, ED may be considered an additional, early warning sign of
coronary atherosclerosis. (J Am Coll Cardiol 2005;46:1503–6) © 2005 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.06.068College of Cardiology Foundation
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prectile dysfunction (ED), defined as the recurrent or
ersistent inability to attain and/or maintain an erection in
rder for satisfactory sexual performance, is present in up to
0 million men in the U.S. and approximately 100 million
en worldwide (1).
Several studies have shown that most cases of ED
ecognize a vascular etiology and are associated with hyper-
ension and diabetes (2,3). Other studies have reported a
igh prevalence of ED in patients with coronary artery
isease (CAD) and a significant correlation between the
everity of ED and the number of vessels involved (4), but
ittle is known about the prevalence, extent, and causes of
oronary artery atherosclerosis in ED patients without
ymptomatic CAD. Coronary artery atherosclerosis can be
etected noninvasively with the use of multi-slice computed
omography (MSCT) (5). The extent of coronary artery
alcification (CAC) correlates with findings on coronary
ngiography and with the extent of atherosclerosis in
athological specimens and is predictive of future cardiac
vents (6,7). We hypothesize that the prevalence and extent
f CAC are higher in patients with ED, as compared with
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edicine, and §Institute of Radiology, University of Modena and Reggio Emilia,
odena, Italy.o
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ccepted June 20, 2005.control group matched for age, race, and coronary risk
core.
ETHODS
ubjects and study design. Between January 2003 and
ovember 2004, we studied 70 patients with ED and 73
ontrol subjects who were frequency-matched for age, race,
all Caucasian), and coronary risk score. Patients were
ecruited from the local endocrinologic clinic specializing in
ale sexual dysfunction. Control subjects were recruited by
dvertisement and from a database of volunteers maintained
y the Policlinico Hospital at Modena University School of
edicine. Erectile dysfunction was evaluated by using the
nternational Index of Erectile Function (IIEF-5) (8), an
bbreviated form of the IIEF used to classify ED, with four
tems selected from the erectile domain portion of the IIEF
nd one addressing sexual satisfaction. The degree of ED is
lassified by the erectile function domain score as complete
4), severe (5 to 10), moderate (11 to 14), mild (15 to 18),
r none (19 to 20).
Patients with ED underwent a penile Doppler examina-
ion to exclude nonvascular causes of ED. Information was
btained through an interview, physical examination, labo-
atory tests, vascular reactivity, MSCT, and, in the case of
atients, penile Doppler examination.
We calculated an expected 10-year risk of cardiac deathr nonfatal myocardial infarction with range estimates
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II risk calculator (9).
enile Doppler examination. Penile Doppler studies were
erformed using the Knoll/Midus ultrasonic velocitometric
ystem (Urometrics, St. Paul, Minnesota). Measurement
ncluded peak systolic velocity (PSV), end-diastolic velocity
EDV), and resistance index (RI  PSV  EDV/PSV). All
atients received 10 to 20 g of intracavernosal prostaglandin
-1, and measurements were performed at 5 and 15 min after
njection to determine the PSV, EDV, and RI. Erectile
ysfunction was determined to be vascular in origin if PSV was
35 cm/s or RI was 0.9 (10).
rachial artery reactivity. An ultrasound study of the
rachial artery was performed in all participants by means of
n Acuson 128 XP/10 mainframe with a 7.0-MHz linear
rray transducer (Acuson, Mountain View, California). The
echnique for assessing brachial artery flow-mediated dila-
ion (FMD) has been described in detail elsewhere (11). In
rief, FMD was assessed by measuring the change in
rachial artery diameter after 60 s of reactive hyperemia
ompared with baseline measurements after deflation of a
uff placed around the forearm that had been inflated to 50
m Hg above systolic blood pressure for 5 min. Increase in
iameter after sublingual nitroglycerin (0.4 mg) was used as
measure of endothelium-independent vasodilation
itroglycerin-mediated dilation (NMD). The response of
he vessel diameter to reactive hyperemia and nitroglycerin
as expressed as percent change relative to the diameter
mmediately before cuff inflation and to the diameter imme-
iately before drug administration, respectively.
oronary calcification. All subjects were examined with a
ight Speed Plus multi-slice scanner (GE Medical Systems,
ilwaukee, Wisconsin). All images were obtained in a
ingle breath hold using 320 mAs and 140 Kv. A section
hickness of 2.5 mm, a field of view of 20 cm, and a matrix
f 512  512 were used to reconstruct the raw image data,
ielding a nominal pixel size of 0.39  0.39 mm2 and a
oxel volume of 0.4 mm3. Image acquisition was triggered
o the 80% R-R interval. Images were then transferred to a
orkstation that enables coronary calcium quantification by
eans of the “Smart Score” software (GE Medical Sys-
ems). The degree of CAC was calculated according to both
gatston and volume score, as previously described (12,13).
e chose to report only calcium score based on volumetric
Abbreviations and Acronyms
CAC  coronary artery calcification
CAD  coronary artery disease
ED  erectile dysfunction
FMD  flow-mediated dilation
IIEF  International Index of Erectile Function
MSCT  multi-slice computed tomography
NMD  nitroglycerin-mediated dilationethod, because this measure is known to be better repro- Fucible and comparable and represents a physical quantita-
ive measure.
tatistical analysis. Data are expressed as mean  SD,
edian (and interquartile range) for variables with a skewed
istribution, or percentage. Comparisons between patients
ith ED and controls were made by means of two-sample
tests or Mann-Whitney U tests (in the case of non-normal
istribution) for continuous variables and by chi-square
nalysis for categorical variables. The prevalence of CAC
percent with positive scores 0), as well as the prevalence
f coronary calcification at/or above the median and 75th
ercentile, were compared between ED patients and control
ubjects. The independent association between ED and
AC was estimated by using multiple logistic regression
nalysis performed after adjustment for traditional coronary
isk factors. Odds ratios and their 95% confidence intervals
ere reported. The difference in the rates of increase in the
revalence of CAC according to age between patients and
ontrols was also assessed by using logistic regression.
tatistical significance was deemed to be p  0.05.
ESULTS
he two groups were similar in respect to all demographic
ariables and risk factors for coronary disease (Table 1). The
ean IIEF-5 score was 12.7  1.5 in the ED group and
2.1  1.4 in the control group (p  0.001). All ED
atients had evidence of penile vascular disease. Mean peak
ystolic velocity measured by penile Doppler was 27.5  3.5
/s. Patients with ED had significantly higher high-sensitivity
-reactive protein levels (hs-CRP) (median 2.62; interquartile
ange: 2.05 to 3.44 mg/l vs. median 1.03; interquartile range:
.78 to 1.26 mg/l; p  0.001).
Brachial artery FMD was significantly lower in ED
atients compared to the controls (2.36  1.75 vs. 3.92 
.2; p  0.001); conversely, NMD was not statistically
ifferent between the two groups (8.36  3.27 vs. 9.50 
.50; p  0.09).
The prevalence of CAC and calcium score in ED patients
nd control subjects is shown in Table 2.
The overall prevalence was higher among the patients
han the controls (odds ratio 2.57; 95% confidence interval,
.26 to 5.26; p  0.01). Mean CAC score was 32.4  59.2
range 0 to 380) in the controls and 143.3  230 (range 0
o 1,470) in the patients. Low and high levels of CAC were
efined with the use of a calcium score above or below the
edian calcium score of patients with calcification (65,
ccording to the volumetric method). In the patients, the
dds ratios for having high levels of coronary calcification
with the absence of calcification used as the reference level)
ere 6.35 (95% confidence interval, 2.35 to 17.16). Among
D patients, 41.4% had a calcium score above the 75th
ercentile compared with 19.1% of the control group (p 
.004) (Table 2). The results did not change significantly by
sing multiple logistic regression analysis adjusted for the
ramingham risk score, diabetes, and body mass index.
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D patients than in control subjects, and the rate of increase
n the prevalence of calcium with age was significantly higher
n patients than in control subjects (p  0.01) (Fig. 1).
ISCUSSION
he main finding in our study is that the prevalence and
xtent of asymptomatic atherosclerosis, as detected by
SCT, is significantly higher among patients with ED and
annot be predicted by the presence of traditional risk
actors for cardiovascular disease. We also found that
atients with ED had significantly impaired endothelial-
ependent FMD and subclinical inflammation compared to
he controls. These data suggest that ED may be the earliest
anifestation of a generalized vascular disease and that
hese patients may be at an increased risk of later developing
AD.
On the basis of current knowledge of erectile physiology,
he close relation between ED and coronary disease does not
Table 1. Clinical Characteristics of Patients W
Characteristics
Pati
(n 
Age, yrs 50.9 
Diabetes, % 14
Smokers, %
Never 65
Current 24
Former 10
Family history, % 22
Systolic pressure, mm Hg 132.5 
Diastolic pressure, mm Hg 78.4 
Body mass index, kg/m2 27.9 
Total cholesterol, mg/dl 193.9 
Low-density lipoprotein, mg/dl 113.2 
High-density lipoprotein, mg/dl 50.5 
Triglycerides, mg/dl 121.2 
Glycemia, mg/dl 106.2 
Lipoprotein (a), mg/dl 23.9 
C-reactive protein, mg/dl* 2.62 (2.0
Framingham risk score 7.2 
Erectile dysfunction score† 12.7 
Penile Doppler PSV, cm/s 27.5 
Values are percentages or mean  SD. *Values are presen
International Index of Erectile Function; ‡Mann-Whitney U
PSV  peak systolic velocity.
able 2. Prevalence of Coronary Artery Calcification and Calcium
Variables
Cases
(n  70)
Controls
(n  73)
oronary artery calcification 75.7 54.8
alcification score†
0 24.3 45.2
1 to 64 24.3 39.7
65 51.4 15.1
olume score 75th percentile 41.4 19.1
alues are percentages. *Logistic regression was used for unadjusted odds ratios. For a
iabetes, and body mass index; †three classes were created according to the median, w
s the reference level in the logistic regression analyses.
CI  confidence interval; OR  odds ratio.epresent a surprise (14). Indeed, ED is often an expression
f endothelial dysfunction, an early event in the atheroscle-
otic process. Kaiser et al. (15) reported a study of 30
atients with ED and no significant cardiovascular risk
actors, well matched with a control group of normal
ubjects, and found an abnormal endothelial-dependent
ow-mediated vasodilation in the brachial artery only in
atients with ED. The difference between the last cited
tudy and the present one is that our population presented
higher profile of CAD risk. However, the impaired
ndothelial function, noted in patients with ED in our
tudy, could not be attributed to the presence of traditional
ardiovascular risk factors because there were no differences
ompared to the control group with respect to Framingham
isk score. In patients with ED, we also found significantly
igher hs-CRP levels, an expression of subclinical chronic
nflammation, compared with control subjects. Recent evi-
ence suggests that CRP directly affects the vascular endo-
helium by inducing chemokines and adhesion molecules
rectile Dysfunction and Controls
Controls
(n  73) p Value
50.1  6.2 0.48
9.6 0.39
65.8 0.73
20.6
13.7
21.9 0.89
7 133.3  10.7 0.64
79.2  6.1 0.71
27.1  2.5 0.08
7 194.3  46.9 0.96
0 112.1  31.6 0.86
4 50.9  13.9 0.88
8 119.8  54.6 0.89
4 103.4  15.2 0.32
3 22.8  7.9 0.83‡
4) 1.03 (0.78–1.26) 0.001
7.1  4.8 0.96
22.1  1.4 0.001
— —
median with interquartile range; †based on the five-item
was used.
re in Cases and Controls
Unadjusted Adjusted
(95% CI) p Value OR (95% CI) p Value
(1.26–5.26) 0.01 2.91 (1.30–6.52) 0.01
1.0 — 1.0 —
(0.49–2.64) 0.76 1.14 (0.43–2.99) 0.92
(2.35–17.16) 0.001 10.38 (3.53–30.52) 0.001
(1.41–6.32) 0.004 3.68 (1.62–8.34) 0.002
odds ratios, logistic regression was used after adjustment for Framingham risk score,
was 65. The first class is 0 that corresponds to absence of calcification, and it is usedith E
ents
70)
6.7
.3
.7
.3
.0
.9
10.
5.9
2.8
51.
39.
13.
58.
17.
13.
5–3.4
5.0
1.5
3.5
ted asSco
OR
2.57
1.14
6.35
2.98
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osis is an inflammatory disease (17), and numerous studies
onfirmed the independent prognostic relevance of CRP for
he risk of CAD, not only in patients with stable or unstable
AD but also in apparently healthy men (18). Erectile
ysfunction, therefore, may be considered as the clinical
anifestation of a disease affecting penile circulation as a
art of a more generalized vascular disorder. Clinical man-
festations of vascular diseases rarely appear simultaneously
n the same patient. The precise mechanisms by which a
pecific district is more prone to the development of
ymptomatic disease are not known. This may occur because
f different sizes of various vascular beds. The penis may be
more sensitive vascular bed to systemic disease because of
he small diameter of the cavernosal arteries than the larger
essels in the heart. So far, the prevalence of coronary artery
therosclerosis in patients with ED remains unknown be-
ause it is difficult to measure noninvasively. In the present
tudy we used MSCT to study subjects with no history of
ardiovascular disease, and we found an increased preva-
ence of CAC among patients with ED independently by
raditional risk factors. Thus, to identify asymptomatic
atients with ED who are at high risk for cardiovascular
vents, the use of the Framingham risk score alone is
nsufficient, and the use of novel markers of risk should be
xplored. Coronary artery calcification may be such a marker
ecause high calcium score is associated with an increased
robability of developing CAD (19).
In conclusion, the present study suggests that ED would
epresent an early clinical manifestation of a diffuse subclin-
cal vascular disease. We are aware of the limitations of this
tudy, which are the small sample size and the cross-
ectional study design; therefore, the conclusions need to be
onfirmed by other studies. If so, ED should be used together
ith other cardiovascular risk factors to discriminate patients
igure 1. Prevalence of coronary calcification among patients with erectile
ysfunction (black bars) and control subjects (white bars), according to age.eeding further investigation for subclinical CAD.eprint requests and correspondence: Dr. Emilio Chiurlia,
nstitute of Cardiology, University of Modena and Reggio Emilia,
ia del Pozzo 71, Modena, Italy. E-mail: emiliochiurlia@virgilio.it.
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